Summary
The FDA has approved Merck's new once-daily cholesterol pill, Lipfendra (enlicitide), marking it as the first oral PCSK9 inhibitor available. This approval introduces a new option for managing cholesterol.
FDA Approves Merck's New Once-Daily Cholesterol Pill, Lipfendra
News Studio
Science
18 July 2026 at 7:16 am
FDA Approves Merck's New Once-Daily Cholesterol Pill, Lipfendra
News Studio
Related & trending news
4.5-Billion-Year-Old Meteorite Crashes in New Jersey, Yields Clues to Life's Origins
18 Jul 2026, 1:21 am · Science
NASA's Chandra and IXPE Study Pulsar Magnetic Fields in Lighthouse Nebula
18 Jul 2026, 7:17 am · Science
NASA's Psyche Mission Captures Detailed Martian Surface Images During Flyby
18 Jul 2026, 7:17 am · Science
NASA Invites Media to Roman Space Telescope and Crew-13 Mission Launches
18 Jul 2026, 7:16 am · Science
China's Giant Sinkholes Protect Endangered Trees While Posing Genetic Diversity Challenge
18 Jul 2026, 1:17 am · Science
Study Finds Human Voices Near Salmon Streams Cause Bears and Eagles to Flee
17 Jul 2026, 9:16 pm · Science